Joint Pain
The Koto University medical study is outlined in the article, published by Suite 101 on June 2, 2009, in layman terms. Two new drugs have been approved by the FDA for rheumatoid arthritis. The article explores the benefits weighted against the toxic effects of the drug combination.
Autoimmune Disease & Joint Pain
Rheumatoid arthritis is an autoimmune disease, and is hard or impossible to manage until now, according to the article. The author has converted the language of the Koto University medical study, “B Cell Depletion Therapy Using Anti-CD20 Antibodies in Rheumatoid Arthritis,” into understandable language.
Osteoporosis Link to Rheumatoid Arthritis Symptoms
The characteristics of rheumatoid arthritis are similar to osteoporosis, according to the article. Explained, is the problem of effective treatment and how two drugs, rituximab and methotrexate (amethopterin)
What Causes Rheumatoid Arthritis
The article quotes from medical sources about how someone can know if they have rheumatoid arthritis. Also, how B cell markers can contribute to the advancement of the disease, and how the drug combination can slow this progress.
To Read the Article Paste the Link Below Into Your Browser:
http://arthritis.suite101.com/
Photo:
http://www.prlog.org/
